Gonadotrophins Versus Clomifene Citrate with or Without Intrauterine Insemination in Women with Normogonadotropic Anovulation and Clomifene Failure (M-OVIN): A Randomized, Two-by-Two Factorial Trial

Nienke S. Weiss, Marleen J. Nahuis, Esmee Bordewijk, Jurjen E. Oosterhuis, Jesper M.J. Smeenk, Annemieke Hoek, Frank J.M. Broekmans, Kathrin Fleischer, Jan Peter De Bruin, Eugenie M. Kaaijk, Joop S.E. Laven, Dave J. Hendriks, Marie H. Gerards, Ilse A.J. Van Rooij, Petra Bourdrez, Judith Gianotten, Carolien Koks, Cornelis B. Lambalk, Peter G. Hompes, Fulco Van Der VeenBen Willem J. Mol, Madelon Van Wely

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)

Abstract

Clomifene citrate has long been used as a first-line ovulation induction agent for women wishing to conceive who have normogonadotropic anovulation (absent or irregular ovulation). Women who ovulate but do not conceive after several cycles with clomifene citrate are usually switched to ovulation induction with gonadotrophins, with or without intrauterine insemination. However, no randomized clinical trials have investigated the effectiveness of a switch to gonadotrophins and intrauterine insemination compared with continued treatment with clomifene citrate.
Original languageEnglish
Pages (from-to)283-284
Number of pages2
JournalObstetrical and Gynecological Survey
Volume73
Issue number5
DOIs
Publication statusPublished - 1 May 2018

Fingerprint

Dive into the research topics of 'Gonadotrophins Versus Clomifene Citrate with or Without Intrauterine Insemination in Women with Normogonadotropic Anovulation and Clomifene Failure (M-OVIN): A Randomized, Two-by-Two Factorial Trial'. Together they form a unique fingerprint.

Cite this